RankingsPricing
  1. US-listed companies
  2. CAPRICOR THERAPEUTICS, INC.
  3. Financials
  4. Operating margin (%)

CAPRICOR THERAPEUTICS, INC.CAPR

Market cap
$1.2B
P/E ratio
SummaryFinancials
Period EndOperating margin (%) YoY (%)
Dec 31, 2024-191.1+99.86%
Dec 31, 2023-95.6-91.78%
Dec 31, 2022-1,163.9-86.39%
Dec 31, 2021-8,549.9+93.76%
Dec 31, 2020-4,412.6+473.42%
Dec 31, 2019-769.5-16.09%
Dec 31, 2018-917+90.10%
Dec 31, 2017-482.4+13.62%
Dec 31, 2016-424.6+85.74%
Dec 31, 2015-228.6+81.81%
Dec 31, 2014-125.7+4.71%
Dec 31, 2012-120.1-54.98%
Dec 31, 2011-266.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)